Current Promotions

No active promotions at the moment. Check back later for special offers!

No video available

Get in Touch

Call Now Visit Website

About

YM BioSciences Inc. is a life sciences product development company advancing a diverse portfolio of promising hematology and cancer-related products at various stages of development. YM has proven regulatory and clinical trial expertise and a diversified business model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization.

YM BioSciences is currently advancing three late-stage products:

•CYT387: JAK 1/2 small molecule inhibitor initially targeting the treatment of a group of hematological disorders known as myeloproliferative neoplasms (MPNs), also known as myeloproliferative disorders.

•Nimotuzumab: EGFR-targeting Affinity-Optimized Antibody™ in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemoradiation; approved for marketing in 25 countries.

•CYT997: novel anti-cancer Vascular Disrupting Agent (VDA) in Phase II clinical development for the treatment of a variety of tumors.

Keywords

No keywords available

Amenities

No amenities listed yet

Upcoming Events

No upcoming events scheduled

Frequently Asked Questions

No FAQs available for this business.

Reviews

No reviews yet. Be the first to review!

Social Links

Photo Gallery

No photos available

Contact Information

Business Info

16
1994
$5.0M

Business Hours

Business hours not available

Own This Business?

Unclaimed

Take control of your business page to update information, respond to reviews, and more.

Claim This Business